Literature DB >> 11732343

The existence and significance of redox-cycling ubiquinone in lysosomes.

H Nohl1, L Gille.   

Abstract

Ubiquinone is inhomogeneously distributed in subcellular biomembranes. Apart from mitochondria, where ubiquinone was demonstrated to exert bioenergetic and pathophysiological functions, unusually high levels of ubiquinone were also reported to exist in Golgi vesicles and lysosomes. In lysosomes the interior differs from other organelles by the low pH value which is important not only to arrest proteins but also to ensure optimal activity of proteases. Since redox cycling of ubiquinone is associated with the acceptance and release of protons, we assumed that ubiquinone is a part of a redox chain contributing to unilateral proton distribution. A similar function of ubiquinone was earlier reported to exist in Golgi vesicles. Support for the involvement of ubiquinone in a presumed couple of redox carriers came from our observation that almost 70% of total lysosomal ubiquinone was in the divalently reduced state. Further reduction was seen in the presence of external NADH. Analysis of the components involved in the transfer of reducing equivalents from cytosolic NADH to ubiquinone revealed the existence of a flavin adenine dinucleotide-containing NADH dehydrogenase. The latter was found to reduce ubiquinone by means of a b-type cytochrome. Proton translocation into the interior was linked to the activity of the novel lysosomal redox chain. Oxygen was found to be the terminal electron acceptor thereby also regulating acidification of the lysosomal matrix. The role of the proton-pumping redox chain has to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11732343     DOI: 10.1007/BF01289407

Source DB:  PubMed          Journal:  Protoplasma        ISSN: 0033-183X            Impact factor:   3.356


  15 in total

Review 1.  Spin trapping: ESR parameters of spin adducts.

Authors:  G R Buettner
Journal:  Free Radic Biol Med       Date:  1987       Impact factor: 7.376

2.  The existence of a lysosomal redox chain and the role of ubiquinone.

Authors:  L Gille; H Nohl
Journal:  Arch Biochem Biophys       Date:  2000-03-15       Impact factor: 4.013

3.  Isolation of highly purified lysosomes from rat liver: identification of electron carrier components on lysosomal membranes.

Authors:  K Arai; T Kanaseki; S Ohkuma
Journal:  J Biochem       Date:  1991-10       Impact factor: 3.387

4.  Iodixanol: a nonionic iso-osmotic centrifugation medium for the formation of self-generated gradients.

Authors:  T Ford; J Graham; D Rickwood
Journal:  Anal Biochem       Date:  1994-08-01       Impact factor: 3.365

5.  Characterization of partially purified cytochromes P-450 and P-448 from rat liver microsomes.

Authors:  A Y Lu; S B West; D Ryan; W Levin
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

6.  Nitrite reductase activity is a novel function of mammalian mitochondria.

Authors:  A V Kozlov; K Staniek; H Nohl
Journal:  FEBS Lett       Date:  1999-07-02       Impact factor: 4.124

7.  Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions.

Authors:  J K Lang; K Gohil; L Packer
Journal:  Anal Biochem       Date:  1986-08-15       Impact factor: 3.365

8.  Purification and characterization of lysosomal H(+)-ATPase. An anion-sensitive v-type H(+)-ATPase from rat liver lysosomes.

Authors:  K Arai; A Shimaya; N Hiratani; S Ohkuma
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

9.  Ubisemiquinones of the mitochondrial respiratory chain do not interact with molecular oxygen.

Authors:  H Nohl; K Stolze
Journal:  Free Radic Res Commun       Date:  1992

10.  A new species of bound ubisemiquinone anion in QH2: cytochrome c oxidoreductase.

Authors:  S de Vries; S P Albracht; J A Berden; E C Slater
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

View more
  1 in total

1.  Modulation of Coenzyme Q10 content and oxidative status in human dermal fibroblasts using HMG-CoA reductase inhibitor over a broad range of concentrations. From mitohormesis to mitochondrial dysfunction and accelerated aging.

Authors:  Fabio Marcheggiani; Ilenia Cirilli; Patrick Orlando; Sonia Silvestri; Alexandra Vogelsang; Anja Knott; Thomas Blatt; Julia M Weise; Luca Tiano
Journal:  Aging (Albany NY)       Date:  2019-05-10       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.